These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3631680)

  • 1. Past, present, and future immunotherapy of snake venom poisoning.
    Sullivan JB
    Ann Emerg Med; 1987 Sep; 16(9):938-44. PubMed ID: 3631680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.
    Consroe P; Egen NB; Russell FE; Gerrish K; Smith DC; Sidki A; Landon JT
    Am J Trop Med Hyg; 1995 Nov; 53(5):507-10. PubMed ID: 7485708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous antivenin in clinical snake venom poisoning. A preliminary report.
    PARRISH HM
    Mo Med; 1963 Mar; 60():240-4. PubMed ID: 13941591
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.
    Wagstaff SC; Laing GD; Theakston RD; Papaspyridis C; Harrison RA
    PLoS Med; 2006 Jun; 3(6):e184. PubMed ID: 16737347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyvalent antivenin in treatment of experimental snake venom poisoning.
    MINTON SA
    Am J Trop Med Hyg; 1954 Nov; 3(6):1077-82. PubMed ID: 13207562
    [No Abstract]   [Full Text] [Related]  

  • 6. Snake venom poisoning in the United States: a review of therapeutic practice.
    Gold BS; Wingert WA
    South Med J; 1994 Jun; 87(6):579-89. PubMed ID: 8202764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snake venom poisoning in the United States.
    Russell FE
    Annu Rev Med; 1980; 31():247-59. PubMed ID: 6994610
    [No Abstract]   [Full Text] [Related]  

  • 8. Snake venoms in science and clinical medicine. 2. Applied immunology in snake venom research.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(6):741-4. PubMed ID: 2617643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraspecificity of antivenins: example of severe envenomation by the Sahara horned viper (Cerastes cerastes) treated with non-specific antivenin].
    Aissaoui Y; Kichna H; Boughalem M; Drissi Kamili N
    Med Sante Trop; 2013; 23(1):100-3. PubMed ID: 23695188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neutralizing recombinant single chain antibody, scFv, against BaP1, A P-I hemorrhagic metalloproteinase from Bothrops asper snake venom.
    Castro JM; Oliveira TS; Silveira CR; Caporrino MC; Rodriguez D; Moura-da-Silva AM; Ramos OH; Rucavado A; Gutiérrez JM; Magalhães GS; Faquim-Mauro EL; Fernandes I
    Toxicon; 2014 Sep; 87():81-91. PubMed ID: 24887282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA; Isbister GK
    Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of antivenoms in the treatment of snake envenomation].
    Chippaux JP
    Bull Acad Natl Med; 2013; 197(4-5):993-1006; discussion 1006-8. PubMed ID: 25518165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vipera palaestinae antivenin.
    Moroz C
    Public Health Rev; 1998; 26(3):233-6. PubMed ID: 10444960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous antivenin in neutralization of North American coral snake venom.
    KEEGAN HL; WHITTEMORE FW; FLANIGAN JF
    Public Health Rep (1896); 1961 Jun; 76(6):540-2. PubMed ID: 13752144
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new ELISA for determination of potency in snake antivenoms.
    Rial A; Morais V; Rossi S; Massaldi H
    Toxicon; 2006 Sep; 48(4):462-6. PubMed ID: 16893558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological properties of Hypnale hypnale (hump-nosed pit viper) venom: antibody production with diagnostic and therapeutic potentials.
    Tan CH; Tan NH; Sim SM; Fung SY; Gnanathasan CA
    Acta Trop; 2012 Jun; 122(3):267-75. PubMed ID: 22322247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive hemagglutination studies with snake venom and antivenin.
    Boche RD; Russell FE
    Toxicon; 1968 Oct; 6(2):125-30. PubMed ID: 5721657
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of IgGT from hyperimmune horse anti-snake venom serum: its protective ability.
    Fernandes I; Takehara HA; Mota I
    Toxicon; 1991; 29(11):1373-9. PubMed ID: 1814013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in the poisoned patient. Overview of present applications and future trends.
    Sullivan JB
    Med Toxicol; 1986; 1(1):47-60. PubMed ID: 3537615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.